Literature DB >> 3663222

HPLC-purified 2-[125I]iodomelatonin labels multiple binding sites in hamster brain.

L P Niles1, D S Pickering, B G Sayer.   

Abstract

Binding of 2-[125I]iodomelatonin in hamster brain synaptosomal membranes at 0 degrees C is rapid, saturable, reversible and sensitive to heat and trypsin treatment. Computer resolution of curvilinear Scatchard plots yielded high- and low-affinity components as follows: Kd1 = 0.32 +/- 0.14 nM, Bmax1 = 5.6 +/- 1.7 fmol/mg protein and Kd2 = 10.5 +/- 3.2 nM, Bmax2 = 123 +/- 33 fmol/mg protein (n = 3). Competition experiments indicated that 2-iodomelatonin and prazosin are the most potent inhibitors of high-affinity binding. Unlike prazosin, several alpha-adrenergic agents and various neurotransmitters were ineffective. These findings suggest that prazosin may be a potent antagonist at a unique, non-alpha-adrenergic, high-affinity binding site for melatonin.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3663222     DOI: 10.1016/s0006-291x(87)80162-6

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  4 in total

Review 1.  Central melatonin receptors: implications for a mode of action.

Authors:  P J Morgan; L M Williams
Journal:  Experientia       Date:  1989-10-15

2.  Expression of melatonin receptors in arteries involved in thermoregulation.

Authors:  M Viswanathan; J T Laitinen; J M Saavedra
Journal:  Proc Natl Acad Sci U S A       Date:  1990-08       Impact factor: 11.205

3.  Picomolar-affinity binding and inhibition of adenylate cyclase activity by melatonin in Syrian hamster hypothalamus.

Authors:  L P Niles; F Hashemi
Journal:  Cell Mol Neurobiol       Date:  1990-12       Impact factor: 5.046

Review 4.  Pharmacology of ramelteon, a selective MT1/MT2 receptor agonist: a novel therapeutic drug for sleep disorders.

Authors:  Masaomi Miyamoto
Journal:  CNS Neurosci Ther       Date:  2009       Impact factor: 5.243

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.